Y-mAbs Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Y-mAbs Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Y-mAbs Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel, antibody-based therapeutic products for cancer treatment. They utilize technologies such as their investigational Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform and bispecific antibodies generated using the Y-BiClone platform. Their product pipeline includes DANYELZA (naxitamab-gqgk), an FDA-approved treatment for relapsed or refractory neuroblastoma.
Business Model
Development and commercialization of novel, antibody-based therapeutic cancer products, including radioimmunotherapy.
Target Customers
Patients with cancer, particularly those with neuroblastoma, and healthcare providers.
Specific Focus
Antibody-based therapeutic products for cancer, with a focus on pediatric oncology and radioimmunotherapy.
Location
New York, New York
CEO
Michael Rossi
Industry
Life sciences
Sub Sector
Biopharmaceutical
3yr Revenue Growth
309%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Y-mAbs Therapeutics, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Y-mAbs Therapeutics, Inc.? Our platform provides detailed analysis of Y-mAbs Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Y-mAbs Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Y-mAbs Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Y-mAbs Therapeutics, Inc. operates in the specialized Biopharmaceutical sub-sector. Understanding how Y-mAbs Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceutical space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
UgoWork
Hardware & Semiconductors • Hardware & semiconductors (including electronic devices)
UgoWork is a pioneering technology company specializing in advanced lithium-ion power solutions for the material handling industry. They develop, manufacture, and distribute a fully integrated batteries and cloud software ecosystem that provides actionable insights and helps optimize daily operations and costs for fleet operators. UgoWork's Energy as a Service (EaaS) model is tailored for the material handling industry, serving diverse sectors including food and beverage, manufacturing, transportation, and distribution across North America.
Catalyst Pharmaceuticals, Inc.
Health Care • Life sciences
A commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients with rare and difficult-to-treat diseases.
Regrow Ag
Energy & Sustainability Technology • Energy & sustainability technology
Regrow Ag is a software company specializing in scalable decarbonization solutions for agriculture. Using satellite imagery and proprietary biogeochemical modeling, they measure and reduce scope 3 emissions on farms. They aim to be a one-stop shop for the agriculture industry's climate needs, offering an Agriculture Resilience Platform fostering collaboration across the global food value chain.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Y-mAbs Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free